Table 5 Comparisons of clinical characteristics according to disease progression in patients with subnephrotic range proteinuria
From: Factors affecting the long-term outcomes of idiopathic membranous nephropathy
Progression to NS (N = 26) | No progressiona (N = 39) | P-value | |
|---|---|---|---|
Male | 9 (34.6%) | 23 (58.9%) | 0.124 |
Age (years) | 53 ± 11 | 47 ± 13 | 0.088 |
BMI (kg/m2) | 23.5 ± 2.3 | 23.9 ± 2.8 | 0.513 |
Hypertension | 8 (28.6%) | 8 (20.5%) | 0.558 |
Serum creatinine (mg/dl) | 0.90 ± 0.18 | 1.11 ± 0.80 | 0.230 |
Serum albumin (g/dl) | 2.67 ± 0.61 | 3.36 ± 0.48 | <0.001 |
Serum cholesterol (mg/dl) | 274.1 ± 92.4 | 225.3 ± 62.4 | 0.018 |
CKD stage according to eGFR | 0.399 | ||
Stage I | 14 (53.8%) | 14 (35.9%) | |
Stage II | 10 (38.5%) | 18 (46.1%) | |
Stage III | 1 | 4 (10.3%) | |
Stage IV-V | 1 | 3 (7.7%) | |
Serum hemoglobin (g/dL) | 12.4 ± 2.2 | 13.4 ± 1.9 | 0.073 |
Proteinuria (g/g creatinine) | 2.46 ± 0.73 | 1.83 ± 0.92 | 0.005 |